Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Swain

Showing results (101-110 of 157) with videos related to

Pageof 16
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 10, 2002
Spirocyclic NK(1) antagonists II: [4.5]-spiroethersBrian J Williams, Margaret A Cascieri, Gary G Chicchi, et al.
Nature Communications|November 6, 2025
A unique inhibitor conformation selectively targets the DNA polymerase PolC of Gram-positive priority pathogensMia Urem, Annemieke H Friggen, Nina Musch, et al.
Cells|June 24, 2022
Using Extracellular Vesicles Released by GDNF-Transfected Macrophages for Therapy of Parkinson DiseaseYuling Zhao, Matthew J Haney, John K Fallon, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2001
2-Aryl indole NK1 receptor antagonists: optimisation of the 2-aryl ring and the indole nitrogen substituentK Dinnell, G G Chicchi, M J Dhar, et al.
ACS Medicinal Chemistry Letters|December 18, 2020
Escaping from Flatland: Antimalarial Activity of sp<sup>3</sup>-Rich Bridged Pyrrolidine DerivativesBrian Cox, James Duffy, Victor Zdorichenko, et al.
Journal of Medicinal Chemistry|May 27, 2025
Design and Mechanistic Analysis of a Potent Bivalent Inhibitor of Transthyretin Amyloid FibrillogenesisP Patrizia Mangione, Guglielmo Verona, Cristina Cantarutti, et al.
Neurogastroenterology and Motility|June 2, 2012
Platelet-derived growth factor receptor α (PDGFRα)-expressing "fibroblast-like cells" in diabetic and idiopathic gastroparesis of humansM Grover, C E Bernard, P J Pasricha, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2002
Spirocyclic NK(1) antagonists I: [4.5] and [5.5]-spiroketalsEileen M Seward, Emma Carlson, Timothy Harrison, et al.
Journal of Medicinal Chemistry|November 16, 2001
An orally active, water-soluble neurokinin-1 receptor antagonist suitable for both intravenous and oral clinical administrationT Harrison, A P Owens, B J Williams, et al.
Bioorganic & Medicinal Chemistry Letters|June 18, 2002
4,4-Disubstituted cyclohexylamine NK(1) receptor antagonists IJason M Elliott, Jose L Castro, Gary G Chicchi, et al.
Pageof 16

Showing results (101-110 of 157) with videos related to

Sort By:
Pageof 16
Bioorganic & Medicinal Chemistry Letters|September 10, 2002
Spirocyclic NK(1) antagonists II: [4.5]-spiroethersBrian J Williams, Margaret A Cascieri, Gary G Chicchi, et al.
Nature Communications|November 6, 2025
A unique inhibitor conformation selectively targets the DNA polymerase PolC of Gram-positive priority pathogensMia Urem, Annemieke H Friggen, Nina Musch, et al.
Cells|June 24, 2022
Using Extracellular Vesicles Released by GDNF-Transfected Macrophages for Therapy of Parkinson DiseaseYuling Zhao, Matthew J Haney, John K Fallon, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2001
2-Aryl indole NK1 receptor antagonists: optimisation of the 2-aryl ring and the indole nitrogen substituentK Dinnell, G G Chicchi, M J Dhar, et al.
ACS Medicinal Chemistry Letters|December 18, 2020
Escaping from Flatland: Antimalarial Activity of sp<sup>3</sup>-Rich Bridged Pyrrolidine DerivativesBrian Cox, James Duffy, Victor Zdorichenko, et al.
Journal of Medicinal Chemistry|May 27, 2025
Design and Mechanistic Analysis of a Potent Bivalent Inhibitor of Transthyretin Amyloid FibrillogenesisP Patrizia Mangione, Guglielmo Verona, Cristina Cantarutti, et al.
Neurogastroenterology and Motility|June 2, 2012
Platelet-derived growth factor receptor α (PDGFRα)-expressing "fibroblast-like cells" in diabetic and idiopathic gastroparesis of humansM Grover, C E Bernard, P J Pasricha, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2002
Spirocyclic NK(1) antagonists I: [4.5] and [5.5]-spiroketalsEileen M Seward, Emma Carlson, Timothy Harrison, et al.
Journal of Medicinal Chemistry|November 16, 2001
An orally active, water-soluble neurokinin-1 receptor antagonist suitable for both intravenous and oral clinical administrationT Harrison, A P Owens, B J Williams, et al.
Bioorganic & Medicinal Chemistry Letters|June 18, 2002
4,4-Disubstituted cyclohexylamine NK(1) receptor antagonists IJason M Elliott, Jose L Castro, Gary G Chicchi, et al.
Pageof 16